|
1
|
Peri M, Botteri E, Pisa E, De Marinis F,
Ungaro A, Spada F, Grana CM, Gasparri R, Spaggiari L, Romentz N,
Badalamenti G, Russo A and Fazio N: A single-institution
retrospective analysis of metachronous and synchronous metastatic
bronchial neuroendocrine tumors. J Thorac Dis. 10:3928–3939.
2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Eloesser L: Transthoracic bronchotomy for
removal of benign tumors of the bronchi. Ann Surg. 112:1067–1070.
1940.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Stanford WR, Davis JE, Gunter JU and
Hobart SG Jr: Bronchial adenoma (carcinoid type) with solitary
metastasis and associated functioning carcinoid syndrome. South Med
J. 51:449–454. 1958.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Arrigoni MG, Woolner LB and Bernatz PE:
Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg.
64:413–421. 1972.PubMed/NCBI
|
|
5
|
Baudin E, Hayes AR, Scoazec JY, Filosso
PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudla B, Gorbunova V,
et al: Unmet medical needs in pulmonary neuroendocrine (Carcinoid)
neoplasms. Neuroendocrinology. 108:7–17. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
La Rosa S, Volante M, Uccella S,
Maragliano R, Rapa I, Rotolo N, Inzani F, Siciliani A, Granone P,
Rindi G, et al: ACTH-producing tumorlets and carcinoids of the
lung: Clinico-pathologic study of 63 cases and review of the
literature. Virchows Arch. 475:587–597. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yamamuro T, Inoue K, Nagai Y, Azuma D,
Yamamoto A, Hara K, Kohara M, Iwata T, Nakatsuka S, Morii E and
Yamamoto T: A case of ectopic ACTH syndrome due to DDAVP-sensitive
but V1b receptor-negative bronchial typical carcinoid with
lymphatic metastasis and plasma ProGRP elevation. Endocr J.
65:1161–1169. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Warren WH, Gould VE, Faber LP, Kittle CF
and Memoli VA: Neuroendocrine neoplasms of the bronchopulmonary
tract. A classification of the spectrum of carcinoid to small cell
carcinoma and intervening variants. J Thorac Cardiovasc Surg.
89:819–825. 1985.PubMed/NCBI
|
|
9
|
Guenter RE, Aweda T, Carmona Matos DM,
Whitt J, Chang AW, Cheng EY, Liu XM, Chen H, Lapi SE and
Jaskula-Sztul R: Pulmonary carcinoid surface receptor modulation
using histone deacetylase inhibitors. Cancers (Basel).
11(767)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Garg R, Kumar R, Singh P and Kshetrimayum
S: Atypical carcinoid tumor of the lung: A rare entity. Lung India.
36:236–238. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Grigoroiu M, Tagett R, Draghici S, Dima S,
Nastase A, Florea R, Sorop A, Ilie V, Bacalbasa N, Tica V, et al:
Gene-expression profiling in non-small cell lung cancer with
invasion of mediastinal lymph nodes for prognosis evaluation.
Cancer Genomics Proteomics. 12:231–242. 2015.PubMed/NCBI
|
|
12
|
Betser L, De Wolf J, Glorion M and
Chapelier A: Use of 3-dimensional computed tomography for planning
a complex sleeve bronchoplasty with total parenchyma-sparing
resection of a carcinoid tumour in the right main bronchus.
Interact Cardiovasc Thorac Surg. 29:638–640. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Scoazec JY: Lung and digestive
neuroendocrine neoplasms From WHO classification to biomarker
screening: Which perspectives? Ann Endocrinol (Paris). 80:163–165.
2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zabaleta J, Aguinagalde B, Lopez I, Laguna
SM, Mendoza M, Galardi A, Matey L, Larranaga A, Baqueriza G and
Izeta A: Creation of a multidisciplinary and multicenter study
group for the use of 3D printing in general thoracic surgery:
Lessons learned in our first year experience. Med Devices (Auckl).
12:143–149. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Altinay S, Metovic J, Massa F, Gatti G,
Cassoni P, Scagliotti GV, Volante M and Papotti M: Spread through
air spaces (STAS) is a predictor of poor outcome in atypical
carcinoids of the lung. Virchows Arch. 475:325–334. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Alrajhi NN, Paramasivam MP, Alboukai AA,
Alrikabi AC and Alhamad EH: Diffuse idiopathic pulmonary
neuroendocrine cell hyperplasia: Unusual presentation. Ann Thorac
Med. 14:161–163. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Viswanathan K, Borczuk AC and Siddiqui MT:
Orthopedia homeobox protein (OTP) is a sensitive and specific
marker for primary pulmonary carcinoid tumors in cytologic and
surgical specimens. J Am Soc Cytopathol. 8:39–46. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Grondahl V, Binderup T, Langer SW,
Petersen RH, Nielsen K, Kjaer A, Federspiel B and Knigge U:
Characteristics of 252 patients with bronchopulmonary
neuroendocrine tumours treated at the Copenhagen NET Centre of
excellence. Lung Cancer. 132:141–149. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sparaneo A, Fabrizio FP, la Torre A,
Graziano P, Di Maio M, Fontana A, Bisceglia M, Rossi A, Pizzolitto
S, De Maglio G, et al: Effects of KEAP1 silencing on the regulation
of NRF2 activity in neuroendocrine lung tumors. Int J Mol Sci.
20(2531)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tutar N, Yetkin NA, Yazici C, Onal O,
Kontas O and Kelestemur F: Clinical significance of
progastrin-releasing peptide, neuron-specific enolase, chromogranin
a, and squamous cell cancer antigen in pulmonary neuroendocrine
tumors. Turk J Med Sci. 49:774–781. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tastepe AI, Kurul IC, Demircan S, Liman
ST, Kaya S and Cetin G: Long-term survival following bronchotomy
for polypoid bronchial carcinoid tumours. Eur J Cardiothorac Surg.
14:575–577. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shariff MZ, Curras-Martin D, Campbell N,
Gupta V, Mikhail JD, Levitt MJ and Hossain MA: Carcinoid tumor of
lung and BRCA mutation: A case report. J Med Case Rep.
13(132)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cattoni M, Vallieres E, Brown LM,
Sarkeshik AA, Margaritora S, Siciliani A, Filosso PL, Guerrera F,
Imperatori A, Rotolo N, et al: Sublobar resection in the treatment
of peripheral typical carcinoid tumors of the lung. Ann Thorac
Surg. 108:859–865. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wegner RE, Abel S, Hasan S, Horne ZD,
Colonias A, Weksler B and Verma V: The role of adjuvant therapy for
atypical bronchopulmonary carcinoids. Lung Cancer. 131:90–94.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Benito-Martinez E, Galeano-Valle F,
Gonzalez A, Edgar MA, Oprea-Ilies G, Ioachimescu AG and Pasquel FJ:
Ectopic ACTH syndrome with association of multiple pulmonary
sclerosing pneumocytomas and multiple carcinoid tumorlets. J Endocr
Soc. 3:937–942. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dermawan JK and Farver CF: The prognostic
significance of the 8th edition TNM staging of pulmonary carcinoid
tumors: A single institution study with long-term follow-up. Am J
Surg Pathol. 43:1291–1296. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Adrega T, Monteiro JP, Lareiro S, Guerra M
and Vouga L: Surgical treatment of concomitant severe heart disease
and lung cancer. Rev Port Cir Cardiotorac Vasc. 26:27–30.
2019.PubMed/NCBI
|
|
28
|
Pelosi G, Massa F, Gatti G, Righi L,
Volante M, Birocco N, Maisonneuve P, Sonzogni A, Harari S, Albini A
and Papotti M: Ki-67 evaluation for clinical decision in metastatic
lung carcinoids: A proof of concept. Clin Pathol.
12(2632010X19829259)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Torniai M, Scortichini L, Tronconi F,
Rubini C, Morgese F, Rinaldi S, Mazzanti P and Berardi R: Systemic
treatment for lung carcinoids: From bench to bedside. Clin Transl
Med. 8(22)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Rekhtman N, Desmeules P, Litvak AM,
Pietanza MC, Santos-Zabala ML, Ni A, Montecalvo J, Chang JC, Beras
A, Preeshagul IR, et al: Stage IV lung carcinoids: Spectrum and
evolution of proliferation rate, focusing on variants with elevated
proliferation indices. Mod Pathol. 32:1106–1122. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Inada H, Miyajima K, Imai K, Maeda J,
Hagiwara M, Ito T and Ikeda N: Bronchial typical carcinoid
requiring left upper sleeve lobectomy after rigid bronchoscopic
intervention. Kyobu Geka. 71:1097–1101. 2018.PubMed/NCBI(In Japanese).
|
|
32
|
Reuling EMBP, Dickhoff C, Plaisier PW,
Bonjer HJ and Daniels JMA: Endobronchial and surgical treatment of
pulmonary carcinoid tumors: A systematic literature review. Lung
Cancer. 134:85–95. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kuwal A, Chauhan N, Dutt N, Elhence P,
Advani M and Kumar S: Spontaneous partial regression of a carcinoid
tumor: Radiology may not capture the real picture. Turk Thorac J.
20:153–156. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Uchida T, Matsubara H, Sugimura A,
Matsuoka H, Ichihara T and Nakajima H: Spontaneous regression of a
carcinoid tumor that required resection owing to its reappearance
and subsequent enlargement after 2 years: A case report. Int Cancer
Conf J. 8:58–60. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Brcic L, Heidinger M, Sever AZ, Zacharias
M, Jakopovic M, Fediuk M, Maier A, Quehenberger F, Seiwerth S and
Popper H: Prognostic value of cyclin A2 and B1 expression in lung
carcinoids. Pathology. 51:481–486. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dediu M, Horvat T, Tarlea A, Anghel R,
Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C and
Savu C: Adjuvant chemotherapy for radically resected non-small cell
lung cancer: A retrospective analysis of 311 consecutively treated
patients. Lung Cancer. 47:93–101. 2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Galie N, Vasile R, Savu C, Petreanu C,
Grigorie V and Tabacu E: Superior vena cava syndrome -surgical
solution case report. Chirurgia (Bucur). 105:835–838.
2010.PubMed/NCBI(In Romanian).
|
